| 000 | 01881 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516005430.0 | ||
| 264 | 0 | _c20110209 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1477-7827 | ||
| 024 | 7 |
_a10.1186/1477-7827-8-123 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFassbender, Amelie | |
| 245 | 0 | 0 |
_aTRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis. _h[electronic resource] |
| 260 |
_bReproductive biology and endocrinology : RB&E _cOct 2010 |
||
| 300 |
_a123 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCell Fractionation _xmethods |
| 650 | 0 | 4 |
_aEndometriosis _xgenetics |
| 650 | 0 | 4 |
_aEndometrium _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanidines _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteal Phase _xgenetics |
| 650 | 0 | 4 |
_aMicroarray Analysis _xmethods |
| 650 | 0 | 4 |
_aPhenols _xpharmacology |
| 650 | 0 | 4 |
_aProteome _xisolation & purification |
| 650 | 0 | 4 |
_aProteomics _xmethods |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aSpecimen Handling _xmethods |
| 650 | 0 | 4 | _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
| 650 | 0 | 4 |
_aUterine Diseases _xgenetics |
| 700 | 1 | _aSimsa, Peter | |
| 700 | 1 | _aKyama, Cleophas M | |
| 700 | 1 | _aWaelkens, Etienne | |
| 700 | 1 | _aMihalyi, Attila | |
| 700 | 1 | _aMeuleman, Christel | |
| 700 | 1 | _aGevaert, Olivier | |
| 700 | 1 | _aVan de Plas, Raf | |
| 700 | 1 | _ade Moor, Bart | |
| 700 | 1 | _aD'Hooghe, Thomas M | |
| 773 | 0 |
_tReproductive biology and endocrinology : RB&E _gvol. 8 _gp. 123 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1477-7827-8-123 _zAvailable from publisher's website |
| 999 |
_c20267437 _d20267437 |
||